Carisoprodol Tablets, Usp, 350 Mg Tablet
Product Images NDC 63561-0127

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carisoprodol Tablets, Usp, 350 Mg (NDC 63561-0127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granulation Technology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

350 mg Bottle Label-100 Ct. (Cari 350mg 100 Ct.)

This text provides information about a medication called Carisoprodol in the form of tablets. Each tablet contains 350mg of Carisoprodol, and it is recommended to be dispensed in a tight container with a child-resistant closure. The usual dosage instructions are available in the package insert, and it is advised to store the tablets at a temperature between 20°C to 25°C. The medication is manufactured for Granulation Technology, Inc. in Fairfield, NJ, USA.*

FDA Label Image

350 mg Bottle Label-1000 Ct. (Cari 350mg 1000 Ct.)

This is a description of a medication with NDC code 63561-0127-2, containing 1000 tablets of Carisoprodol, USP 350mg each. The tablets should be dispensed in a tight container and stored at a temperature between 20°C to 25°C (68°F to 77°F), following USP Controlled Room Temperature guidelines. The medication is manufactured by Granuation Technology, Inc. and intended for prescription use only.*

FDA Label Image

Carisoprodol Structural Formula (Cari Stru.)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.